New Treatment for Myeloma
Jens Hillengass of Roswell Park Comprehensive Cancer Center, discusses the newly FDA approved immunotherapy combination, Empliciti® (elotuzumab), to tr...
31 articles
Jens Hillengass of Roswell Park Comprehensive Cancer Center, discusses the newly FDA approved immunotherapy combination, Empliciti® (elotuzumab), to tr...
Michael Polydefkis discusses hereditary ATTR amyloidosis and the recently FDA-approved Alnylam's ONPATTRO™, which is the first and only treatment appr...
A significant discovery on how Plasmodium falciparum (the parasite that causes malaria) moves fast to avoid getting caught by the immune cells has been ...
A new treatment for primary axillary hyperhidrosis called Qbrexza (glycopyrronium) has been approved by the US Food And Drug Administration (FDA).
Andrew Blauvelt Presenter: Neal Howard Guest Bio: Andy Blauvelt hails from Portland, OR, and is President and Investigator at Oregon Medical Research Ce...
Guest: Dave Lareau Presenter: Neal Howard Guest Bio: In 1978, Medicomp Systems pioneered its patented MEDCIN Knowledge Engine, co-designed with phys...
Health Professional Radio: Dr. Hani Al-Salami discusses healthcare topics with host Patrick Reyes. Learn more on Health Professional Radio.
Health Professional Radio: Dr. Frank Hermann discusses healthcare topics with host Neal Howard. Learn more on Health Professional Radio.
Health Professional Radio: Mark Borsody discusses healthcare topics with host Neal Howard. Learn more on Health Professional Radio.
Health Professional Radio: Dr Michael Freeman discusses healthcare topics with host Wayne Bucklar. Learn more on Health Professional Radio.